Navigation Links
bcl-1/JH, t(11;14) Translocation by PCR, Paraffin

Productsbcl-1/JH, t(11;14) Translocation by PCR, Paraffin
Company ARUP Laboratories
Item bcl-1/JH, t(11;14) Translocation by PCR, Paraffin
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. bcl-1/JH, t(11;14) Translocation by PCR, Fluid
2. bcl-1/JH, t(11;14) Translocation by PCR, Tissue
3. t(11;14) IgH-CCND1 Translocation by FISH
4. AML1-ETO, t(8;21) Translocation by RT-PCR
5. API2-MLT1,t(11;18) Translocation by RT-PCR
6. bcl-2/JH mbr Quantification, t(14;18) Translocation by PCR, Paraffin
7. bcl-2/JH mbr Quantification, t(14;18) Translocation by PCR, Tissue
8. bcl-2/JH, t(14;18) Translocation by PCR, Paraffin
9. bcl-2/JH, t(14;18) Translocation by PCR, Tissue
10. bcr/abl, t(9;22) Translocation Quantitative Assay by RT-PCR
11. bcl-2/JH mbr Quantification, t(14;18) Translocation by PCR, Fluid
...uptures are problem enough for your patients. Now ...unctional treatment for foot and ankle fractures a...TORM. A combination of prefabricated brace and ope...nt with higher standards of safety. The storm can ...
The Active Ankle Trainer model provides medial/lateral support and optimum ankle mobility for chronic and prophylactic use.
The Bledsoe M-Brace Ankle Support reduces ankle swelling while boosting the patient's confidence when its time to get back in the game. The M-Brace is available in two models the Air M-Brace or the
The Bledsoe ST & ST2 Boots are low-cost, lightweight walkers for short term applications. The ST & ST2 are designed to enhance mobility for sprains, strains, and some types of fractures. The Bledsoe
Medicine Products:
(Date:11/21/2008)...ate University College of Medicine research team l...w layer of regulation in the cell division cycle, ... way cancer begins. , Wang, an assistant profess...ne, said the findings will lead to an improved abi...gn of new drugs that kill cancer cells by inhibiti...
(Date:11/21/2008)...SNewswire/ -- The Generic,Pharmaceutical Associat...from,GPhA President and CEO Kathleen Jaeger regar...e on "Emerging Health Care Competition and Consume... conducting this roundtable demonstrates the,grow...ccess to safe and,affordable biogenerics sooner r...
(Date:11/21/2008)...e-USNewswire/ -- New research at West Virginia Un...ss tobacco product aimed at young adults is catchi...olds, Camel Snus - touted as a socially acceptable...high levels of nicotine. , , "Camel Snus co...s," said Bruce Adkins of the state Division of Tob...
(Date:11/21/2008)...wire-FirstCall/ -- Today, prescription drugs are t...ng 88 percent of patients suffering chronic condit...hronic condition account for 96 percent of all pre...cal costs. A proprietary new pharmacy model devel...nc. (NYSE: MHS ) significantly reduces critical ...
Breaking Medicine News(10 mins):Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6
...iocon has launched an anti-cancer drug called Biom...Bangalore. Biocon's CMD, Ms Kiran Mazumdar-Shaw to...ercent of what similar drugs marketed by MNCs cost...ue of MAb developers worldwide. We want to be a ke...
...early 360 mobile teams have been pressed into serv...eck the outbreak of water-borne and other seasonal.../ "There was always a possibility of the outbreak ...s because of the presence of moisture in the atmos...
...fter viral fever, malaria and dengue, a more letha...city.// As per official reports, no case of chikun...s with its symptoms are being treated. Their sampl...ratory. "We have already started a survey in the...
... recent study has shown that taking four short wal...beneficial than one long walk.// Indiana Universit... of the Journal of Hypertension, a study that comp...ks to one 40-minute walk which revealed that blood...
Other Medicine News:Health News:Chikungunya Outbreak Feared in Jaipur 2
(Date:11/20/2008)..., , , PHILADELPHIA, Nov. 20 /PRNewswire... announced that the United States Food and Drug Ad...r PROMACTA(R) (eltrombopag) for the treatment of t...diopathic) thrombocytopenic purpura (ITP) who have...immunoglobulins or splenectomy. The approval is a ...
(Date:11/20/2008)...DE, Calif., Nov. 20 Milk. It does ...an originally thought. After years of,research, s...tides found in,cow,s milk that stimulate the body... view the Multimedia News Release, go to:, http://... While developing new cancer therapies, the c...
(Date:11/20/2008)...GE, Mass., Nov. 20 Radius Health (...ditional $15 million to its second institutional f...nt to $82.5 million and the total amount raised si... existing institutional investors participated in ...d and including MPM Capital, The Wellcome Trust, H...
(Date:11/20/2008)...MSO, Norway, November 20 The Scand...harma has announced results of studies on its,lea...AAC in Washington, DC,the studies showed that th...acteriocidal effect, significantly better towards ...yogenes than marketed gold standard drugs. In,add...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2Rigel to Present at the Oppenheimer 19th Annual Healthcare Conference 28053 1Riverock Technologies Helps Misukanis 26amp 3B Odden Eliminate Task Management Obstacles 8684 1Riverock Technologies Helps Misukanis 26amp 3B Odden Eliminate Task Management Obstacles 8684 2Riverock Technologies Helps Misukanis 26amp 3B Odden Eliminate Task Management Obstacles 8684 3SkinMedica Hosts Aesthetics Division National Sales Meeting 28050 1SkinMedica Hosts Aesthetics Division National Sales Meeting 28050 2SkinMedica Hosts Aesthetics Division National Sales Meeting 28050 3No Difference in Rate of Survival for Children of Different Races Undergoing Liver Transplantation but Long Term Results Not as Good for African Amer 28048 1No Difference in Rate of Survival for Children of Different Races Undergoing Liver Transplantation but Long Term Results Not as Good for African Amer 28048 2No Difference in Rate of Survival for Children of Different Races Undergoing Liver Transplantation but Long Term Results Not as Good for African Amer 28048 3
...25, 2007 - GTx, Inc., (NASDAQ:,GTXI) announced tod...cept clinical trial of Ostarine(TM) and from the o...NE(R) (toremifene citrate) 80,mg for the treatment...therapy (ADT) will be presented at the upcoming 20...cal Oncology being,held June 1 - 5 at McCormick Pl...
...y 24, 2007 - A new analysis,has found that many al...inadvertently omit women and African-Americans fro... Medicine,researcher who led the effort said the f...tudy eligibility criteria can have,unintended, neg... of 100,000 alcohol treatment,patients, Keith Hump...
Other Medicine Technology:GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 2GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 3Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 2Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 3